Publicacions en què col·labora amb Rosa Ayesa Arriola (16)

2023

  1. Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 14

2022

  1. Ten-year course of cognition in first-episode non-affective psychosis patients: PAFIP cohort

    Psychological Medicine, Vol. 52, Núm. 4, pp. 770-779

2019

  1. Verbal memory and voxel based morphometry in first episode non-Affective psychosis: A process oriented approach

    Neuropsychology, Vol. 33, Núm. 4, pp. 568-580

2016

  1. Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 266, Núm. 7, pp. 619-628

  2. Evidence for trait related theory of mind impairment in first episode psychosis patients and its relationship with processing speed: A 3 year follow-up study

    Frontiers in Psychology, Vol. 7, Núm. MAY

2015

  1. Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis

    Cognitive Neuropsychiatry, Vol. 20, Núm. 2, pp. 144-156

2014

  1. Lack of insight 3 years after first-episode psychosis: An unchangeable illness trait determined from first presentation?

    Schizophrenia Research, Vol. 157, Núm. 1-3, pp. 271-277

  2. No sex differences in neuropsychological performance in first episode psychosis patients

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 48, pp. 149-154

2013

  1. Course of cognitive deficits in first episode of non-affective psychosis: A 3-year follow-up study

    Schizophrenia Research, Vol. 150, Núm. 1, pp. 121-128

  2. Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: A randomized comparison of haloperidol, olanzapine, and risperidone

    Psychopharmacology, Vol. 227, Núm. 4, pp. 615-625

  3. Predictors of neurocognitive impairment at 3years after a first episode non-affective psychosis

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 43, pp. 23-28

2012

  1. Homocysteine and cognition in first-episode psychosis patients

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 262, Núm. 7, pp. 557-564

2011

  1. Insight dimensions in first-episode psychosis patients: Clinical, cognitive, pre-morbid and socio-demographic correlates

    Early Intervention in Psychiatry, Vol. 5, Núm. 2, pp. 140-149

2010

  1. Cannabis use and cognitive functioning in first-episode schizophrenia patients

    Schizophrenia Research, Vol. 124, Núm. 1-3, pp. 142-151

  2. White matter integrity and cognitive impairment in first-episode psychosis

    American Journal of Psychiatry, Vol. 167, Núm. 4, pp. 451-458

2009

  1. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: A randomized, controlled 1-year follow-up comparison

    Journal of Clinical Psychiatry, Vol. 70, Núm. 5, pp. 717-729